NEUROPACE, INC. Cost of Revenue
NEUROPACE, INC. (NPCE) reported Cost of Revenue of $3.92 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-11
- NEUROPACE, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $3.92M, a 19.22% increase year-over-year.
- NEUROPACE, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $4.02M, a 22.42% decline year-over-year.
- NEUROPACE, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $6.01M, a 13.87% increase year-over-year.
- NEUROPACE, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $6.19M, a 9.68% increase year-over-year.
- NEUROPACE, INC. cost of goods and services sold for fiscal 2025 was $22.77M, a 9.34% increase from fiscal 2024.
- NEUROPACE, INC. cost of goods and services sold for fiscal 2024 was $20.82M, a 20.36% increase from fiscal 2023.
- NEUROPACE, INC. cost of goods and services sold for fiscal 2023 was $17.30M, a 32.79% increase from fiscal 2022.
- NEUROPACE, INC. cost of goods and services sold for fiscal 2022 was $13.03M, a 10.89% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3.92M 10-Q · filed 2026-08-11 | $7.91M 10-Q · filed 2026-08-11 | $13.95M derived: sum of 3 quarters · filed 2026-08-11 | $20.14M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | $4.02M 10-Q · filed 2026-05-12 | $10.03M derived: sum of 2 quarters · filed 2026-05-12 | $16.22M derived: sum of 3 quarters · filed 2026-05-12 | $19.50M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | $6.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $12.20M derived: sum of 2 quarters · filed 2026-03-03 | $15.48M derived: sum of 3 quarters · filed 2026-08-11 | $22.77M 10-K · filed 2026-03-03 | ||
| 2025-09-30 | $6.19M 10-Q · filed 2025-11-04 | $9.47M derived: sum of 2 quarters · filed 2026-08-11 | $16.76M 10-Q · filed 2025-11-04 | $19.93M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | $3.29M 10-Q · filed 2026-08-11 | $5.39M 10-Q · filed 2025-08-12 | $6.48M 10-Q · filed 2026-08-11 | $10.57M 10-Q · filed 2025-08-12 | $13.75M derived: sum of 3 quarters · filed 2026-08-11 | $19.39M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $5.18M 10-Q · filed 2026-05-12 | $10.46M derived: sum of 2 quarters · filed 2026-05-12 | $16.10M derived: sum of 3 quarters · filed 2026-05-12 | $21.22M derived: sum of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | $5.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $10.92M derived: sum of 2 quarters · filed 2026-03-03 | $16.04M derived: sum of 3 quarters · filed 2026-03-03 | $20.82M 10-K · filed 2026-03-03 | ||
| 2024-09-30 | $5.64M 10-Q · filed 2025-11-04 | $10.76M derived: sum of 2 quarters · filed 2025-11-04 | $15.54M 10-Q · filed 2025-11-04 | $20.01M derived: sum of 4 quarters · filed 2025-11-04 | ||
| 2024-06-30 | $5.12M 10-Q · filed 2025-08-12 | $9.90M 10-Q · filed 2025-08-12 | $14.37M derived: sum of 3 quarters · filed 2025-08-12 | $18.56M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | $4.78M 10-Q · filed 2025-05-13 | $9.25M derived: sum of 2 quarters · filed 2025-05-13 | $13.44M derived: sum of 3 quarters · filed 2025-05-13 | $17.98M derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | $4.47M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $8.66M derived: sum of 2 quarters · filed 2025-03-04 | $13.20M derived: sum of 3 quarters · filed 2025-03-04 | $17.30M 10-K · filed 2025-03-04 | ||
| 2023-09-30 | $4.19M 10-Q · filed 2024-11-12 | $8.73M derived: sum of 2 quarters · filed 2024-11-12 | $12.83M 10-Q · filed 2024-11-12 | $16.82M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $4.54M 10-Q · filed 2024-08-13 | $8.64M 10-Q · filed 2024-08-13 | $12.62M derived: sum of 3 quarters · filed 2024-08-13 | $15.82M derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $4.10M 10-Q · filed 2024-05-08 | $8.09M derived: sum of 2 quarters · filed 2024-05-08 | $11.28M derived: sum of 3 quarters · filed 2024-05-08 | $14.01M derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2022-12-31 | $3.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $7.18M derived: sum of 2 quarters · filed 2024-03-05 | $9.91M derived: sum of 3 quarters · filed 2024-03-05 | $13.03M 10-K · filed 2024-03-05 | ||
| 2022-09-30 | $3.19M 10-Q · filed 2023-11-06 | $5.93M derived: sum of 2 quarters · filed 2023-11-06 | $9.04M 10-Q · filed 2023-11-06 | $11.96M derived: sum of 4 quarters · filed 2023-11-06 | ||
| 2022-06-30 | $2.73M 10-Q · filed 2023-08-08 | $5.85M 10-Q · filed 2023-08-08 | $8.77M derived: sum of 3 quarters · filed 2023-08-08 | $11.60M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | $3.12M 10-Q · filed 2023-05-04 | $6.04M derived: sum of 2 quarters · filed 2023-05-04 | $8.87M derived: sum of 3 quarters · filed 2023-05-04 | $12.14M derived: sum of 4 quarters · filed 2023-05-04 | ||
| 2021-12-31 | $2.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $5.75M derived: sum of 2 quarters · filed 2023-03-02 | $9.02M derived: sum of 3 quarters · filed 2023-03-02 | $11.75M 10-K · filed 2023-03-02 | ||
| 2021-09-30 | $2.83M 10-Q · filed 2022-11-08 | $6.10M derived: sum of 2 quarters · filed 2022-11-08 | $8.83M 10-Q · filed 2022-11-08 | $11.36M derived: sum of 4 quarters · filed 2022-11-08 | ||
| 2021-06-30 | $3.27M 10-Q · filed 2022-08-11 | $6.00M 10-Q · filed 2022-08-11 | $8.53M derived: sum of 3 quarters · filed 2022-08-11 | $11.72M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $2.72M 10-Q · filed 2022-05-12 | $5.26M derived: sum of 2 quarters · filed 2022-05-12 | $8.45M derived: sum of 3 quarters · filed 2022-05-12 | $10.67M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $5.73M derived: sum of 2 quarters · filed 2022-03-10 | $7.95M derived: sum of 3 quarters · filed 2022-03-10 | $10.87M 10-K · filed 2022-03-10 | ||
| 2020-09-30 | $3.20M 10-Q · filed 2021-11-10 | $5.42M derived: sum of 2 quarters · filed 2021-11-10 | $8.33M 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $2.22M 10-Q · filed 2021-08-12 | $5.14M 10-Q · filed 2021-08-12 | ||||
| 2020-03-31 | $2.92M 10-Q · filed 2021-06-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |